SNPXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	6 874.00
平均出来高	49 649.00
時価総額	4.92M
EPS	$0 ( 2024-04-02 )
次の収益日	( $0 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.150
ATR14	$0.0710 (1.57%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Singer William S.	Buy	800	Stock Option (Right to Buy)
2024-04-08	Silverman Joshua	Buy	800	Stock Option (Right to Buy)
2024-04-08	Schechter Jonathan	Buy	800	Stock Option (Right to Buy)
2024-04-08	Bernstein Bruce	Buy	800	Stock Option (Right to Buy)
2023-03-29	Schechter Jonathan	Buy	20 000	Stock Option (Right to Buy)

INSIDER POWER
74.96
Last 71 transactions
Buy: 1 845 200 \| Sell: 283 116

Synaptogenix, Inc. 相関

10 最も正の相関
GOSS	0.958
VORB	0.946
BCAB	0.946
THTX	0.944
XFOR	0.943
FATE	0.942
NVTSW	0.941
RIVN	0.939
NCBS	0.938
ISPO	0.938

10 最も負の相関
NWLI	-0.967
AMYT	-0.967
EZGO	-0.959
RXDX	-0.956
TACO	-0.956
MLCO	-0.955
LUNA	-0.954
HZNP	-0.953
EXAS	-0.953
MLVF	-0.953

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Synaptogenix, Inc. 財務諸表

Annual	2023
収益:	$0
総利益:	$-6 347.00 (0.00 %)
EPS:	$-12.96

FY	2023
収益:	$0
総利益:	$-6 347.00 (0.00 %)
EPS:	$-12.96

FY	2022
収益:	$0
総利益:	$-5 714.00 (0.00 %)
EPS:	$-0.780

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-2.51

Financial Reports:

No articles found.

Synaptogenix, Inc.

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.